The study, published in Gastroenterology , identified that drugs such as Ozempic and Wegovy, which are glucagon-like peptide-1 receptor agonists (GLP-1RAs) used in the management of diabetes and obesity, could lead to a higher chance of developing aspiration pneumonia after undergoing endoscopy procedures
I've been prescribing it off label for a while
The shortage that allowed for compounding exceptions applied specifically to injectable GLP-1 medications
These data support an effect of IL-13 to decrease total and reduced GSH through high 15LO1, PEBP1, and GPX4 activity, which is partially compensated by (a) increased expression/activity of SLC7A11 to enhance new intracellular GSH production and (b) increased export of GSSG
Key takeaways Ozempic is not approved for weight loss, but it is often prescribed off-label for weight management
Storage Do not store above 30C